2023 ACR/ACCP Guidelines: Treating ILD in Systemic Autoimmune Rheumatic Diseases

In this video, we explore the 2023 guidelines on the treatment of Interstitial Lung Disease (ILD) associated with systemic autoimmune rheumatic diseases, published by the American College of Rheumatology (ACR) and the American College of Chest Physicians (ACCP). These guidelines offer comprehensive recommendations for the management of ILD in the context of conditions such as systemic sclerosis, rheumatoid arthritis, and other autoimmune diseases. We will cover key aspects of diagnosis, treatment options, and how to manage ILD progression in these complex cases.

Designed for rheumatologists, pulmonologists, and other healthcare professionals, this video provides valuable insights to improve clinical decision-making and patient outcomes in ILD associated with systemic autoimmune diseases.


🔗 Useful Links:

ACR/ACCP 2023 Guidelines: https://acrjournals.onlinelibrary.wil...
📌 Hashtags: #ILD #ACR2023 #ACCP2023 #Rheumatology #Pulmonology #InterstitialLungDisease #AutoimmuneDisease #HealthcareProfessionals #ConnectiveTissueDisease

Disclaimer: This video is intended for healthcare professionals (HCPs) only. It provides educational information based on the latest clinical guidelines and is not a substitute for professional medical advice. Always consult the relevant guidelines and clinical protocols.